Prostate cancer diagnoses followed the rapid increase in the detection of early-stage prostate cancers during the early to mid-1990s with the introduction of PSA testing, which is largely responsible for the increase of prostate cancer incidence levels [50,51]. Here, KLK3 is linked to prostate carcinoma.